Addex Therapeutics (ADXN) Asset Utilization Ratio: 2022-2025
Historic Asset Utilization Ratio for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to -42.04.
- Addex Therapeutics' Asset Utilization Ratio fell 42561.60% to -42.04 in Q2 2025 from the same period last year, while for Jun 2025 it was -42.04, marking a year-over-year decrease of 42561.60%. This contributed to the annual value of 0.05 for FY2024, which is 79.53% down from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Asset Utilization Ratio is -42.04, which was down 1,298.06% from -3.01 recorded in Q1 2025.
- Over the past 5 years, Addex Therapeutics' Asset Utilization Ratio peaked at 0.33 during Q1 2024, and registered a low of -42.04 during Q2 2025.
- Its 3-year average for Asset Utilization Ratio is -4.35, with a median of 0.16 in 2024.
- Per our database at Business Quant, Addex Therapeutics' Asset Utilization Ratio surged by 109.99% in 2023 and then slumped by 42,561.60% in 2025.
- Quarterly analysis of 4 years shows Addex Therapeutics' Asset Utilization Ratio stood at 0.14 in 2022, then surged by 109.99% to 0.29 in 2023, then crashed by 88.08% to 0.03 in 2024, then tumbled by 42,561.60% to -42.04 in 2025.
- Its Asset Utilization Ratio stands at -42.04 for Q2 2025, versus -3.01 for Q1 2025 and 0.03 for Q4 2024.